65,437 trials
Coronary Artery Disease
Primary: Acute Device Success — 49 Participants
Acute Kidney Injury
Primary: Mortality — 96; 34 Participants — p=<0.0001
Stress, Psychological · Stress, Physiological · Anxiety
Primary: Cohen Perceived Stress Scale to Measure Stress — 23.28; 19.31 score on a scale
Depression · Anxiety
Primary: Usage Rating Profile-Intervention Revised (URP-IR), Feasibility Subscale — 30.00; 30.00 score on a scale
Type 2 Diabetes
Primary: Percent Change in Platelet Activity (MPA) Before and After Cholesterol Reduction — -5; -7 percent change in platelet aggregation
Diabetes Mellitus, Type 1
Primary: Maximal Glucagon Concentration During Hypoglycemia — 19.9; 22.5; 82.7 pg/mL
Obstructive Sleep Apnea · Tonsillitis · Pain, Procedural
Primary: Total Amount of Opioid Medications Administered — 1.5; 0.9; 0.5 morphine mg equivalents/kg — p=0.045
Trigeminal Neuralgia
Primary: Time to Return to Baseline Pain After Injection. — 8; 5 hours — p=0.374
Type 2 Diabetes
Primary: Peak Change in From Baseline in Reactive Oxygen Species (ROS) Generation — 224; 167 percentage of change
Chronic Post-Surgical Pain
Primary: Preoperative Chronic Pain Severity — 4.6; 4.4 units on a scale
Obesity · Overweight
Primary: Total Number of Steps Per Day — 8756; 7334 Steps per day
CMV Infection · Persistent CMV Viremia
Primary: Complete Response — 20; 57 Participants
Cervical Dysplasia · Cervical High Grade Squamous Intraepithelial Lesion · HSIL
Primary: Baseline Biomarker-positive Participants for ITT Population: Percentage of Participants With No Histologic Evidence of Cervical HSIL on Histology Sample and No Evidence…
Alcohol Use, Unspecified · Sexual Violence · Sexual Assault
Primary: Number of Drinking Days Per Month — 6.45; 5.91 drinking days in the past 30 days — p=0.448
Depression · COVID-19
Primary: Antidepressive Effectiveness of Agomelatine in Patients With Depression Episode Occurred After COVID-19 Assessed by HAMD-17 After 8 Weeks of Treatment in the Daily…